Regencell Bioscience Holdings Limited Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Regencell Bioscience Holdings Limited (RGC) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 24.49 million shares as of 2025-06-30, per its 20-F filed 2025-10-31.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2025-10-31
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 24.49M shares.
- 2024-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 28.67M shares; Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed 754.55K shares.
- 2023-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 800.01K shares.
- 2023-06-29: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 30.40M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed |
|---|---|---|
| 2025-06-30 | 24.49M shares 20-F · filed 2025-10-31 | |
| 2024-06-30 | 28.67M shares 20-F · filed 2025-10-31 | 754.55K shares 20-F · filed 2024-10-25 |
| 2023-06-30 | 800.01K shares 20-F · filed 2024-10-25 | |
| 2023-06-29 | 30.40M shares 20-F · filed 2025-10-31 | |
| 2022-06-30 | 975.33K shares 20-F · filed 2024-10-25 | |
| 2021-06-30 | 1.24M shares 20-F · filed 2023-10-27 |